BRIEF-Arbutus Biopharma Corp - EPO Revokes Arbutus Biopharma's European Patent EP 2279254 - SEC Filing

Reuters

Jan 16

BRIEF-<a href="https://laohu8.com/S/ABUS">Arbutus Biopharma</a> Corp - EPO Revokes Arbutus Biopharma's European Patent EP 2279254 - SEC Filing

Jan 16 (Reuters) - Arbutus Biopharma Corp ABUS.O:

ARBUTUS BIOPHARMA CORP - EPO REVOKES ARBUTUS BIOPHARMA'S EUROPEAN PATENT EP 2279254 - SEC FILING
ARBUTUS BIOPHARMA CORP - DECISION LIKELY TO AFFECT ARBUTUS CASE AGAINST MODERNA IN SWITZERLAND - SEC FILING
ARBUTUS BIOPHARMA CORP - EXPECTS NO IMPACT ON U.S., JAPAN, CANADA LITIGATION - SEC FILING
ARBUTUS BIOPHARMA CORP: CO DISAGREES WITH OUTCOME, PLANS TO FILE PETITION FOR REVIEW BY ENLARGED BOARD OF APPEAL OF EPO

Further company coverage: ABUS.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2603199593"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2603199593\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2603199593?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-16 20:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2603199593","market":"nz","top_or_hot":-1,"title":"BRIEF-Arbutus Biopharma Corp - EPO Revokes Arbutus Biopharma's European Patent EP 2279254 - SEC Filing","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/ABUS\">Arbutus Biopharma</a> Corp - EPO Revokes Arbutus Biopharma's European Patent EP 2279254 - SEC Filing</title></head><body><p><span>Jan 16 (Reuters)</span><span> - </span>Arbutus Biopharma Corp <span>ABUS.O</span>:</p><ul><li><p>ARBUTUS BIOPHARMA CORP - EPO REVOKES ARBUTUS BIOPHARMA'S EUROPEAN PATENT EP 2279254 - SEC FILING</p></li><li><p>ARBUTUS BIOPHARMA CORP - DECISION LIKELY TO AFFECT ARBUTUS CASE AGAINST MODERNA IN SWITZERLAND - SEC FILING</p></li><li><p>ARBUTUS BIOPHARMA CORP - EXPECTS NO IMPACT ON U.S., JAPAN, CANADA LITIGATION - SEC FILING</p></li><li><p>ARBUTUS BIOPHARMA CORP: CO DISAGREES WITH OUTCOME, PLANS TO FILE PETITION FOR REVIEW BY ENLARGED BOARD OF APPEAL OF EPO</p></li></ul><p>Further company coverage: <span>ABUS.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Arbutus Biopharma Corp - EPO Revokes Arbutus Biopharma's European Patent EP 2279254 - SEC Filing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Arbutus Biopharma Corp - EPO Revokes Arbutus Biopharma's European Patent EP 2279254 - SEC Filing\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-16 20:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/ABUS\">Arbutus Biopharma</a> Corp - EPO Revokes Arbutus Biopharma's European Patent EP 2279254 - SEC Filing</title></head><body><p><span>Jan 16 (Reuters)</span><span> - </span>Arbutus Biopharma Corp <span>ABUS.O</span>:</p><ul><li><p>ARBUTUS BIOPHARMA CORP - EPO REVOKES ARBUTUS BIOPHARMA'S EUROPEAN PATENT EP 2279254 - SEC FILING</p></li><li><p>ARBUTUS BIOPHARMA CORP - DECISION LIKELY TO AFFECT ARBUTUS CASE AGAINST MODERNA IN SWITZERLAND - SEC FILING</p></li><li><p>ARBUTUS BIOPHARMA CORP - EXPECTS NO IMPACT ON U.S., JAPAN, CANADA LITIGATION - SEC FILING</p></li><li><p>ARBUTUS BIOPHARMA CORP: CO DISAGREES WITH OUTCOME, PLANS TO FILE PETITION FOR REVIEW BY ENLARGED BOARD OF APPEAL OF EPO</p></li></ul><p>Further company coverage: <span>ABUS.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260116:nFWN3YH1E2:1","article_id":"2603199593","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2603199593","pubTimestamp":1768567532,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Arbutus Biopharma Corp - EPO Revokes Arbutus Biopharma's European Patent EP 2279254 - SEC FilingJan 16  - Arbutus Biopharma Corp ABUS.O:ARBUTUS BIOPHARMA CORP - EPO REVOKES ARBUTUS BIOPHARMA'S EUROPEAN PATENT EP 2279254 - SEC FILINGARBUTUS BIOPHARMA CORP - DECISION LIKELY TO AFFECT ARBUTUS CASE AGAINST MODERNA IN SWITZERLAND - SEC FILINGARBUTUS BIOPHARMA CORP - EXPECTS NO IMPACT ON U.S., JAPAN, CANADA LITIGATION - SEC FILINGARBUTUS BIOPHARMA CORP: CO DISAGREES WITH OUTCOME, PLANS TO FILE PETITION FOR REVIEW BY ENLARGED BOARD OF APPEAL OF EPOFurther company coverage: ABUS.O ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","ABUS":"Arbutus Biopharma Corporation"},"translate_title":"简介-Arbutus Biopharma Corp-EPO撤销Arbutus Biopharma的欧洲专利EP 2279254-SEC申请","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ABUS":0.9},"content_text":"BRIEF-Arbutus Biopharma Corp - EPO Revokes Arbutus Biopharma's European Patent EP 2279254 - SEC FilingJan 16 (Reuters) - Arbutus Biopharma Corp ABUS.O:ARBUTUS BIOPHARMA CORP - EPO REVOKES ARBUTUS BIOPHARMA'S EUROPEAN PATENT EP 2279254 - SEC FILINGARBUTUS BIOPHARMA CORP - DECISION LIKELY TO AFFECT ARBUTUS CASE AGAINST MODERNA IN SWITZERLAND - SEC FILINGARBUTUS BIOPHARMA CORP - EXPECTS NO IMPACT ON U.S., JAPAN, CANADA LITIGATION - SEC FILINGARBUTUS BIOPHARMA CORP: CO DISAGREES WITH OUTCOME, PLANS TO FILE PETITION FOR REVIEW BY ENLARGED BOARD OF APPEAL OF EPOFurther company coverage: ABUS.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}